The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages

被引:260
作者
Scheuerer, B [1 ]
Ernst, M [1 ]
Dürrbaum-Landmann, I [1 ]
Fleischer, J [1 ]
Grage-Griebenow, E [1 ]
Brandt, E [1 ]
Flad, HD [1 ]
Petersen, F [1 ]
机构
[1] Res Ctr Borstel, Dept Immunol & Cell Biol, D-23845 Borstel, Germany
关键词
D O I
10.1182/blood.V95.4.1158.004k31_1158_1166
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Unstimulated monocytes rapidly undergo physiological changes resulting in programmed cell death (apoptosis) while stimuli promoting differentiation of these cells into macrophages were shown to inhibit apoptotic processes. in the present study, we report that the platelet-derived alpha-chemokine platelet factor 4 (PF4) induces the differentiation of monocytes into macrophages, as is evident from morphological changes as well as from the up-regulation of differentiation markers (carboxypeptidase M/MAX1 and CD71). Significant alterations of the phenotype were observed after 72 hours of culture in the presence of the chemokine and required a minimal concentration of 625 nmol/L PF4. PF4-induced macrophages were characterized by a lack of HLA-DR antigen on their surface but showed a strong increase in the expression of the CD28 ligand B7-2. Furthermore, PF4 stimulation prevented monocytes from undergoing spontaneous apoptosis during 72 hours of culture as determined in an annexin-V-binding assay. Although PF4 induced the secretion of relevant amounts of TNF-alpha, neutralizing antibodies directed against TNF-alpha or granulocyte-macrophage colony-stimulating factor (GM-CSF) did not revert PF4-induced rescue from programmed cell death, suggesting that PF4 exerts its antiapoptotic effects in a TNF-alpha- or GM-CSF-independent fashion. On the basis of these results, we propose a novel role for PF4 in the control of monocyte differentiation during an inflammatory process in vivo.
引用
收藏
页码:1158 / 1166
页数:9
相关论文
共 43 条
[11]  
GELSSLER K, 1989, J IMMUNOL, V143, P140
[12]   PLATELET FACTOR-IV INHIBITS THE MITOGENIC ACTIVITY OF VEGF(121) AND VEGF(165) USING SEVERAL CONCURRENT MECHANISMS [J].
GENGRINOVITCH, S ;
GREENBERG, SM ;
COHEN, T ;
GITAYGOREN, H ;
ROCKWELL, P ;
MAIONE, TE ;
LEVI, BZ ;
NEUFELD, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (25) :15059-15065
[13]   An Fc gamma receptor I (CD64)-negative subpopulation of human peripheral blood monocytes is resistant to killing by antigen-activated CD4-positive cytotoxic T cells [J].
GrageGriebenow, E ;
Baran, J ;
Loppnow, H ;
Los, M ;
Ernst, M ;
Flad, HD ;
Pryjma, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (09) :2358-2365
[14]   PHENOTYPICAL AND FUNCTIONAL-CHARACTERIZATION OF FC-GAMMA RECEPTOR-I (CD64)-NEGATIVE MONOCYTES, A MINOR HUMAN MONOCYTE SUBPOPULATION WITH HIGH ACCESSORY AND ANTIVIRAL ACTIVITY [J].
GRAGEGRIEBENOW, E ;
LORENZEN, D ;
FETTING, R ;
FLAD, HD ;
ERNST, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (12) :3126-3135
[15]   Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents [J].
Han, ZC ;
Lu, M ;
Li, JM ;
Defard, M ;
Boval, B ;
Schlegel, N ;
Caen, JP .
BLOOD, 1997, 89 (07) :2328-2335
[16]   NEGATIVE REGULATION OF HUMAN MEGAKARYOCYTOPOIESIS BY HUMAN PLATELET FACTOR 4 (PF4) AND CONNECTIVE TISSUE-ACTIVATING PEPTIDE (CTAP-III) [J].
HAN, ZC ;
BELLUCCI, S ;
WALZ, A ;
BAGGIOLINI, M ;
CAEN, JP .
INTERNATIONAL JOURNAL OF CELL CLONING, 1990, 8 (04) :253-259
[17]  
HAWRYLOWICZ CM, 1989, J IMMUNOL, V143, P4015
[18]   EFFECT OF PLATELET-ACTIVATING-FACTOR AND PLATELET FACTOR-4 ON EOSINOPHIL ADHESION [J].
HAYASHI, N ;
CHIHARA, J ;
KOBAYASHI, Y ;
KAKAZU, T ;
KURACHI, D ;
YAMAMOTO, T ;
NAKAJIMA, S .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1994, 104 :57-59
[19]  
Heidenreich S, 1997, J IMMUNOL, V159, P3178
[20]   CHEMICAL SYNTHESIS OF PHOSPHORYLATED TETRAACYL DISACCHARIDE CORRESPONDING TO A BIOSYNTHETIC PRECURSOR OF LIPID-A [J].
IMOTO, M ;
YOSHIMURA, H ;
YAMAMOTO, M ;
SHIMAMOTO, T ;
KUSUMOTO, S ;
SHIBA, T .
TETRAHEDRON LETTERS, 1984, 25 (25) :2667-2670